Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Net Receivables & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Net Receivables

LCTX Net Receivables

Latest reported$1.56Mperiod endingDec 31, 2025

LCTX FY Net Receivables ($0.00 → $1.56M)

Annual net receivables

High-resolution chart · PNG

LCTX net receivables history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Net Receivables — Annual fiscal periods (USD)
Period ending	Net Receivables (USD)
Dec 31, 2025	1,562,000
Dec 31, 2024	638,000
Dec 31, 2023	745,000
Dec 31, 2022	297,000
Dec 31, 2021	51,140,000
Dec 31, 2020	4,000
Dec 31, 2019	24,740,000
Dec 31, 2018	3,719,000
Dec 31, 2017	3,046,000
Dec 31, 2016	1,157,000
Dec 31, 2015	1,645,000
Dec 31, 2014	1,041,856
Dec 31, 2013	1,115,209
Dec 31, 2012	0
Dec 31, 2011	0
Dec 31, 2010	0
Dec 31, 2009	-138,547
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Jun 30, 1998	0
Jun 30, 1996	0
Jun 30, 1995	0
Jun 30, 1994	0
Jun 30, 1993	0
Jun 30, 1992	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.